Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer - Concepedia

Concepedia

Publication | Open Access

Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer

DOI Full Paper Access

225

Citations

29

References

2011

Year

Beth Y. Karlan, Amit M. Oza, Gary Richardson, Diane Provencher, Vincent Hansen, Martin Buck, Setsuko K. Chambers, Prafull Ghatage, Charles H. Pippitt, John V. Brown,

Journal of Clinical Oncology

Abstract

AMG 386 combined with weekly paclitaxel was tolerable, with a manageable and distinct toxicity profile. The data suggest evidence of antitumor activity and a dose-response effect, warranting further studies in ovarian cancer.

References

	Year	Citations

Page 1